Article
Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of weekly
Rating:
0.0
Views:
7
Likes:
1
Library:
1
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value